Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-13

FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Aurobindo Pharma Limited's generic citalopram hydrobromide, expanding its approved product to market as a generic an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram Hydrobromide (citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)